{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:34:09Z","timestamp":1773308049478,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jbc.2023.104816","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T16:41:03Z","timestamp":1683823263000},"page":"104816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism"],"prefix":"10.1016","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-1407","authenticated-orcid":false,"given":"Christine A.","family":"Juliana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-3907","authenticated-orcid":false,"given":"Pablo","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Rico-Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Betz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-8087","authenticated-orcid":false,"given":"Diva D.","family":"De Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.104816_bib1","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2015-2539","article-title":"High risk of Diabetes and neurobehavioral deficits in individuals with surgically treated hyperinsulinism","volume":"100","author":"Lord","year":"2015","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.104816_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fendo.2013.00060","article-title":"Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism","volume":"4","author":"Avatapalle","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2023.104816_bib3","doi-asserted-by":"crossref","first-page":"E355","DOI":"10.1210\/jc.2012-2169","article-title":"Genotype and phenotype correlations in 417 children with congenital hyperinsulinism","volume":"98","author":"Snider","year":"2013","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.104816_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/EJE-12-0673","article-title":"Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism","volume":"168","author":"Kapoor","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jbc.2023.104816_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.sempedsurg.2010.10.012","article-title":"KATP channel mutations in congenital hyperinsulinism","volume":"20","author":"Saint-Martin","year":"2011","journal-title":"Semin. Pediatr. Surg."},{"key":"10.1016\/j.jbc.2023.104816_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1399-5448.2009.00547.x","article-title":"Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism","volume":"11","author":"Laje","year":"2010","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.jbc.2023.104816_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/pds.4144","article-title":"Octreotide use and safety in infants with hyperinsulinism","volume":"26","author":"McMahon","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jbc.2023.104816_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpedsurg.2018.10.030","article-title":"Surgical treatment of congenital hyperinsulinism: results from 500 pancreatectomies in neonates and children","volume":"54","author":"Adzick","year":"2019","journal-title":"J.\u00a0Pediatr. Surg."},{"key":"10.1016\/j.jbc.2023.104816_bib9","doi-asserted-by":"crossref","first-page":"E1786","DOI":"10.1210\/jc.2013-2094","article-title":"Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases","volume":"98","author":"Lord","year":"2013","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.104816_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1749-6632.2010.05511.x","article-title":"Somatostatin and its receptors from fish to mammals","volume":"1200","author":"Gahete","year":"2010","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.jbc.2023.104816_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350317","article-title":"Molecular pharmacology of somatostatin receptor subtypes","volume":"20","author":"Patel","year":"1997","journal-title":"J.\u00a0Endocrinol. Invest."},{"key":"10.1016\/j.jbc.2023.104816_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000201201","article-title":"Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue","volume":"55","author":"Raulf","year":"1994","journal-title":"Digestion"},{"key":"10.1016\/j.jbc.2023.104816_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mce.2008.02.007","article-title":"Function and expression of somatostatin receptors of the endocrine pancreas","volume":"286","author":"Strowski","year":"2008","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jbc.2023.104816_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/002215540405200310","article-title":"Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats","volume":"52","author":"Ludvigsen","year":"2004","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.jbc.2023.104816_bib15","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1210\/endo.140.8.6937","article-title":"Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells","volume":"140","author":"Mitra","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2023.104816_bib16","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1523\/JNEUROSCI.16-14-04468.1996","article-title":"Localization of the somatostatin receptor SST2A in rat brain using a specific anti-peptide antibody","volume":"16","author":"Dournaud","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2023.104816_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1507\/endocrj.48.95","article-title":"Immunohistochemical localization of somatostatin receptor type 2A in rat and human tissues","volume":"48","author":"Kimura","year":"2001","journal-title":"Endocr. J."},{"key":"10.1016\/j.jbc.2023.104816_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0306-4522(96)00388-0","article-title":"Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord","volume":"76","author":"Schindler","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.jbc.2023.104816_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/bbrc.1994.2670","article-title":"Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs","volume":"205","author":"Rossowski","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2023.104816_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0039-6060(98)70128-X","article-title":"Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse","volume":"124","author":"Fagan","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.jbc.2023.104816_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/endo.141.1.7263","article-title":"Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in\u00a0vitro study of pancreatic islets from somatostatin receptor 2 knockout mice","volume":"141","author":"Strowski","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2023.104816_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1210\/me.2001-0035","article-title":"Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis","volume":"17","author":"Strowski","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jbc.2023.104816_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diabetes.48.1.77","article-title":"Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis","volume":"48","author":"Kumar","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2023.104816_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/cc990017h","article-title":"A\u00a0combinatorial approach toward the discovery of non-peptide, subtype-selective somatostatin receptor ligands","volume":"1","author":"Berk","year":"1999","journal-title":"J.\u00a0Comb. Chem."},{"key":"10.1016\/j.jbc.2023.104816_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.282.5389.737","article-title":"Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry","volume":"282","author":"Rohrer","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.104816_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0928-4257(00)00215-1","article-title":"Identification and characterization of subtype selective somatostatin receptor agonists","volume":"94","author":"Rohrer","year":"2000","journal-title":"J.\u00a0Physiol. Paris"},{"key":"10.1016\/j.jbc.2023.104816_bib27","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1210\/en.2006-1659","article-title":"Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition","volume":"148","author":"Singh","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2023.104816_bib28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0006-2952(99)00010-6","article-title":"Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5","volume":"57","author":"Zambre","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2023.104816_bib29","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/00006676-200311000-00019","article-title":"Activation of somatostatin receptor subtype 2 inhibits insulin secretion in the isolated perfused human pancreas","volume":"27","author":"Brunicardi","year":"2003","journal-title":"Pancreas"},{"key":"10.1016\/j.jbc.2023.104816_bib30","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2337\/diabetes.52.5.1176","article-title":"Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats","volume":"52","author":"Cejvan","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2023.104816_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128807","article-title":"Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism","volume":"71","author":"Zhao","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2023.104816_bib32","doi-asserted-by":"crossref","first-page":"13393","DOI":"10.1074\/jbc.M311502200","article-title":"A\u00a0signaling role of glutamine in insulin secretion","volume":"279","author":"Li","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104816_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/diabetes.50.2.322","article-title":"Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations","volume":"50","author":"Grimberg","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2023.104816_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpeds.2006.02.033","article-title":"Protein-sensitive hypoglycemia without leucine sensitivity in hyperinsulinism caused by K(ATP) channel mutations","volume":"149","author":"Fourtner","year":"2006","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.jbc.2023.104816_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1067\/mpd.2001.111818","article-title":"Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism\/hyperammonemia syndrome","volume":"138","author":"Hsu","year":"2001","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.jbc.2023.104816_bib36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/jc.2006-1578","article-title":"Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in\u00a0vitro study on isolated human pancreatic islets","volume":"92","author":"Singh","year":"2007","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.104816_bib37","doi-asserted-by":"crossref","first-page":"A325","DOI":"10.1210\/jendso\/bvab048.663","article-title":"Selective somatostatin 5 (SST5) and somatostatin 2 (SST2) nonpeptide agonists potently suppress glucose- and tolbutamide-stimulated dynamic insulin secretion from isolated human islets","volume":"5","author":"Elizabeth Rico","year":"2021","journal-title":"J.\u00a0Endocr. Soc."},{"key":"10.1016\/j.jbc.2023.104816_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jmedgenet-2015-103394","article-title":"Congenital hyperinsulinism in children with paternal 11p uniparental isodisomy and Beckwith-Wiedemann syndrome","volume":"53","author":"Kalish","year":"2016","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.jbc.2023.104816_bib39","doi-asserted-by":"crossref","first-page":"F67","DOI":"10.1136\/fn.84.1.F67","article-title":"Hyperinsulinism and beckwith-wiedemann syndrome","volume":"84","author":"Munns","year":"2001","journal-title":"Arch. Dis. Child. Fetal. Neonatal. Ed."},{"key":"10.1016\/j.jbc.2023.104816_bib40","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1210\/en.2009-0600","article-title":"Glucose generates coincident insulin and somatostatin pulses and antisynchronous glucagon pulses from human pancreatic islets","volume":"150","author":"Hellman","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2023.104816_bib41","first-page":"E1043","article-title":"Effects of somatostatin on pulsatile insulin secretion: elective inhibition of insulin burst mass","volume":"270","author":"Porksen","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jbc.2023.104816_bib42","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1073\/pnas.79.21.6502","article-title":"Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells","volume":"79","author":"Heisler","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.104816_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/303177a0","article-title":"A\u00a0nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells","volume":"303","author":"Jakobs","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.104816_bib44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0896-6273(00)80183-X","article-title":"Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin","volume":"17","author":"Renstrom","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2023.104816_bib45","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.01876","article-title":"The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5","volume":"152","author":"Hofland","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jbc.2023.104816_bib46","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.soard.2013.11.006","article-title":"Treatment of severe postRYGB hyperinsulinemic hypoglycemia with pasireotide: a comparison with octreotide on insulin, glucagon, and GLP-1","volume":"10","author":"de Heide","year":"2014","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.jbc.2023.104816_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003272","article-title":"Successful medical treatment of adult nesidioblastosis with pasireotide over 3 Years: a case report","volume":"95","author":"Schwetz","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbc.2023.104816_bib48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.6065\/apem.2142010.005","article-title":"First report on the use of pasireotide in a case of severe congenital hyperinsulinism due to a homozygous ABCC8 mutation","volume":"26","author":"Mooij","year":"2021","journal-title":"Ann Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.104816_bib49","doi-asserted-by":"crossref","first-page":"25786","DOI":"10.1074\/jbc.M804372200","article-title":"Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-\/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion","volume":"283","author":"De Leon","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104816_bib50","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.beem.2013.06.005","article-title":"Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia","volume":"27","author":"De Leon","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2023.104816_bib51","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2337\/db17-0029","article-title":"Functional and metabolomic consequences of KATP channel inactivation in human islets","volume":"66","author":"Li","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2023.104816_bib52","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/19420862.2018.1457599","article-title":"A\u00a0unique allosteric insulin receptor monoclonal antibody that prevents hypoglycemia in the SUR-1(-\/-) mouse model of KATP hyperinsulinism","volume":"10","author":"Patel","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.jbc.2023.104816_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236892","article-title":"Activation of Protein Kinase A (PKA) signaling mitigates congenital hyperinsulinism associated hypoglycemia in the Sur1-\/- mouse model","volume":"15","author":"Soundarapandian","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2023.104816_bib54","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2337\/db12-0166","article-title":"GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel","volume":"61","author":"Calabria","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2023.104816_bib55","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2337\/dc21-2009","article-title":"Exendin-(9-39) effects on glucose and insulin in children with congenital hyperinsulinism during fasting and during a meal and a protein challenge","volume":"45","author":"Stefanovski","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jbc.2023.104816_bib56","series-title":"ABSTRACT PSUN304) CRN04777, an Oral, Nonpeptide SST5-Selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion","author":"Ferrara-Cook","year":"2022"},{"key":"10.1016\/j.jbc.2023.104816_bib57","article-title":"SAT-169 selective nonpeptide somatostatin subtype 5 (sst5) agonists suppress glucose- and sulfonylurea-induced insulin secretion in rats","volume":"3","author":"Emmanuel Sturchler","year":"2019","journal-title":"J.\u00a0Endocr. Soc."},{"key":"10.1016\/j.jbc.2023.104816_bib58","series-title":"Selective Somatostatin Subtype 5 (Sst5) Agonists for the Treatment of Hyperinsulinism: Orally-Bioavailable Small Molecules Suppress Insulin and Rescue Glyburide-Induced Hypoglycemia. ABSTRACT","first-page":"i463","author":"Markison S","year":"2018"},{"key":"10.1016\/j.jbc.2023.104816_bib59","doi-asserted-by":"crossref","first-page":"37176","DOI":"10.1074\/jbc.M206757200","article-title":"Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose","volume":"277","author":"Shiota","year":"2002","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823018446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823018446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:45:23Z","timestamp":1762188323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823018446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0021925823018446"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.104816","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.104816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"104816"}}